XML 41 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes
12. Income Taxes
Total loss before income taxes for the years ended December 31, 2024 and 2023 did not include a foreign component.
The components of the provision (benefit) expense were as follows for the years ended December 31, 2024 and 2023 (in thousands):
 
    
Year Ended December 31,
 
    
  2024  
    
  2023  
 
Current income tax (benefit) expense:
     
Federal
   $ —       $ —   
State
     (1      13  
  
 
 
    
 
 
 
Total current income tax (benefit) expense
     (1      13  
Deferred income tax benefit:
     
Federal
     (16,279      (16,514
State
     (2,803      (11,247
  
 
 
    
 
 
 
Total deferred income tax benefit
     (19,082      (27,761
Changes in tax rate
     2,155        (1,471
Changes in valuation allowance
     16,927        29,232  
  
 
 
    
 
 
 
Total income tax (benefit) expense from continuing operations
   $ (1    $ 13  
  
 
 
    
 
 
 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income
tax purposes.
 
The components of the Company’s net deferred tax liabilities and related valuation allowance are as follows as of December 31, 2024 and 2023 (in thousands):
 
    
Year Ended December 31,
 
    
2024
    
2023
 
Deferred tax assets:
     
Net operating loss carryforwards
   $ 85,226      $ 71,434  
Debt related interest
     16,228        16,898  
Capitalized research and development
     5,228        4,936  
Tax credit carryforwards
     4,415        3,960  
Stock-based compensation
     1,157        525  
Accrued expense and reserves
     1,812        1,584  
Purchased revenue liability
     1,754        —   
Operating lease liabilities
     577        774  
Other
     303        159  
  
 
 
    
 
 
 
Total deferred tax assets
     116,700        100,270  
Less valuation allowance
     (113,703      (96,776
  
 
 
    
 
 
 
Total deferred tax assets
     2,997        3,494  
  
 
 
    
 
 
 
Deferred tax liabilities:
     
Intangible assets
     (2,423      (2,734
Operating lease
right-of-use
assets
     (574      (760
  
 
 
    
 
 
 
Total deferred tax liabilities
     (2,997      (3,494
  
 
 
    
 
 
 
Net deferred tax liabilities
   $ —       $ —   
  
 
 
    
 
 
 
The reconciliation between U.S. federal income taxes at the statutory rate and the Company’s provision for income taxes are as follows for the years ended December 31, 2024 and 2023 (in thousands):
 
    
Year Ended December 31,
 
    
  2024  
    
  2023  
 
Income tax benefit at federal statutory rate
   $ (15,290    $ (24,007
Valuation allowance
     18,559        29,232  
Compensation expense
     2,772        3,798  
Acquisition related charges
     485        260  
Prior year
true-up
and carryback
     (1,182      (5,079
State, net of federal tax benefit
     (2,705      (5,127
Change in fair value of Convertible Debentures
     (4,449      1,752  
Change in tax rates
     2,155        (1,471
Other
     (346      655  
  
 
 
    
 
 
 
Income tax (benefit) expense
   $ (1    $ 13  
  
 
 
    
 
 
 
The Company has evaluated the available evidence supporting the realization of its gross deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that the deferred tax assets will not be realized. Due to such uncertainties surrounding the realization of the deferred tax assets, the Company maintains a valuation allowance of $113.7 million against its deferred tax assets as of December 31, 2024. Realization of the deferred tax assets will be primarily dependent upon the Company’s ability to generate sufficient taxable income prior to the expiration of its net operating losses.
As of December 31, 2024, the Company had $336.5 million and $248.2 million of federal and state net operating loss carryforwards, respectively. The net operating loss carryforwards begin to expire in 2033 for
both federal
 
and state. As
of December 31, 2024, the Company had a total of $313.5 million of federal net operating losses that have an indefinite life and will not expire, and had federal research and development income tax credits of $3.7 million which will begin to expire in 2034. As of December 31, 2024, the Company had California research and development income tax credits of $2.2 million that have an indefinite life and will not expire.
Internal Revenue Code Section 382 rules apply to limit a corporation’s ability to utilize existing net operating loss and tax credit carryforwards once the corporation experiences an ownership change as defined in Section 382. For the years ended December 31, 2024 and 2023, there was no impact of such limitations on the Company’s income tax provision.
The Company is subject to taxation in U.S. federal and state tax jurisdictions. All of the Company’s tax years will remain open for three years for examination by the federal and state tax authorities from the date of utilizations of net operating loss. There are no active tax compliance audits as of December 31, 2024.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows for the years ended December 31, 2024 and 2023 (in thousands):
 
 
  
2024
 
  
2023
 
Gross unrecognized tax benefits at the beginning of the year
   $ 1,071      $ 408  
Increase related to prior year tax positions
     —         536  
Increase related to current year tax positions
     127        127  
  
 
 
    
 
 
 
Gross unrecognized tax benefits at the end of the year
   $ 1,198      $ 1,071  
  
 
 
    
 
 
 
As of December 31, 2024 and 2023, the Company had $1.2 million and $1.1 
million in total unrecognized tax benefits, respectively, which have been reflected as a reduction in deferred tax assets. If these were to be recognized, they would affect the effective tax rate, however given the full valuation allowance in the jurisdiction in which the unrecognized tax benefits relate to, the impact on the effective tax rate would be nil.
The Company’s policy is to recognize interest and penalties related to income tax matters in income tax expense
. No interest or penalties have been recognized as of and for the years ended December 31, 2024 and 2023.
The Company believes that no material amount of the liabilities for uncertain tax positions are expected to reverse within 12 months of
 
December
 
31,
 
2024.